Hemogenyx Pharmaceuticals Plc

LSE (GBp): Hemogenyx Pharmaceuticals Plc (HEMO)

Last Price

1,010.00

Today's Change

-90.00 (8.18%)

Day's Change

972.01 - 1,160.00

Trading Volume

39,441

Overview

Market Cap

61 Million

Shares Outstanding

6 Million

Avg Volume

43,764

Avg Price (50 Days)

646.51

Avg Price (200 Days)

552.42

PE Ratio

-4.37

EPS

-2.31

Earnings Announcement

27-Apr-2026

Previous Close

1100.00

Open

1138.20

Day's Range

972.014 - 1160.0

Year Range

124.0 - 1800.0

Trading Volume

39,441

Price Change Highlight

1 Day Change

-8.18%

5 Day Change

21.72%

1 Month Change

62.64%

3 Month Change

0.00%

6 Month Change

590.60%

Ytd Change

77.82%

1 Year Change

197.50%

3 Year Change

8.37%

5 Year Change

-64.69%

10 Year Change

-99.83%

Max Change

-99.82%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. It is involved in developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML), subset of acute lymphoblastic leukaemia, and myelodysplastic syndrome conditioning bone marrow transplants to substitute traditional chemotherapy and/or radiation; HEMO-CAR-T therapy, a chimeric antigen receptor T-cells to identify and destroy human AML-derived cells in vitro and in vivo; and Human Postnatal Hematopoietic Endothelial Cells, a stem cell therapy product for BM/HSC transplants. The company was founded in 2012 and is headquartered in London, the United Kingdom.

Discussions
Be the first to like this. Showing 0 of 0 comments

{uid}

{comment}

Just now

Post a Comment